NCT05194072 2026-01-09A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid TumorsSeagen Inc.Phase 1 Terminated250 enrolled
NCT03556228 2025-12-11VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaVM Oncology, LLCPhase 1/2 Recruiting242 enrolled